• Genoa in the News

Genoa Healthcare® Chief Executive Officer provides industry outlook in Chain Drug Review article

Feb 2nd, 2024

In the health care industry in 2024, pharmacy teams will continue to play a critical role in providing care in areas with limited access to pharmacy services.

Genoa Healthcare Chief Executive Officer Todd Gustin discussed the expanded role of the pharmacist and what that means for improving access to care in Chain Drug Review’s recent industry outlook article.

“Genoa will continue filling gaps in care for [medically underserved] populations, focusing on providing care in areas where access to pharmacy services is limited,” said Gustin. “Often called pharmacy deserts, these are areas where patients experience significant barriers to accessing their needed medications due to their geographic location and distance from a pharmacy.”

You can read the full article here.

Let’s connect

Want to learn more about offering Genoa pharmacy services to your consumers? Fill out the form below and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...

  • Consumer Stories
  • People-first Pharmacy Care
For people in crisis, access to a safe place is critical

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • People-first Pharmacy Care
Genoa pharmacist saves the life of someone she’s never met

Having witnessed the effects of the opioid crisis in her community firsthand, Genoa Healthcare® Pharmacist Kristen Pyland had prepared for the day she’d need to rush into action to aid...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...